NCT00385320View on ClinicalTrials.gov

Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months

PHASE2CompletedINTERVENTIONAL
Enrollment

2,640

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

April 30, 2003

Study Completion Date

April 30, 2003

Conditions
Infections, Rotavirus
Interventions
BIOLOGICAL

HRV vaccine

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY